Kruit T, Verfaille V, Jellema P, De Jonge A (2013). Inspirerende start van de IRIS-studie! Tijdschrift voor Verloskundigen, 38(7), 28-29.

Verfaille V, Franx A, Jellema P, De Jonge A (2014). De beste stuurlui spreken dezelfde taal! Nederlands Tijdschrift voor Obstetrie en Gynaecologie, 127(2), 60.

Jellema P (2014). Van onderzoeksidee tot wervingsfolder. Tijdschrift voor Verloskundigen, 39(1), 54-55. 

EMGO+ Institute for Health and Care Research (2015). Data collection of the IRIS study has started.

Henrichs, J. (2016). Babysterfte daalt dankzij aandacht voor risicozwangere. Nataal, 30(8), 6-9.

Henrichs J, Verfaille V, Viester L, Westerneng M, Molewijk B, Franx A, et al. Effectiveness and cost-effectiveness of routine third trimester ultrasound screening for intrauterine growth restriction: study protocol of a nationwide stepped wedge cluster-randomized trial in The Netherlands (The IRIS Study). BMC Pregnancy and Childbirth. 2016; 16:310.

Verfaille V, de Jonge A, Mokkink L, Westerneng M, van der Horst H, Jellema P, Franx A and IRIS study group. Multidisciplinary consensus on screening for, diagnosis and management of fetal growth restriction in the Netherlands. BMC Pregnancy and Childbirth. 2017;17:353.


Annual Meeting of the Amsterdam Public Health research institute in Amsterdam
23 november 2017 
Quality assessment of ultrasonic fetal biometry during the IUGR Risk Selection trial: a cross sectional study (V. Verfaille)

International Forum on Quality & Safety in Healthcare in Amsterdam
3-4 mei 2017
Quality assessment of Ultrasonic Fetal Biometry during a Prospective Trial (V. Verfaille)

Congres Kennispoort 2018
19 januari 2018
1. Kwaliteitscontrole van biometrie-echo's gedurende de IRIS (IUGR Risk Selection) studie (V. Verfaille)
2. Hoe ervaren zwangere vrouwen routinematige derde-trimester echo's (M. Westerneng)